Wellcome Trust Creates New Business to Invest in Life Science, Healthcare Firms | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Wellcome Trust announced yesterday that its board has approved the creation of a new business to invest in emerging technologies in the healthcare and life sciences sector.

The new business, called Project Sigma for now, will have an initial investment of £200 million ($317 million), drawn from Wellcome Trust's endowment. A name and brand identity will be announced shortly, Wellcome Trust said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.